Randomized Trial of Intensive Motivational Interviewing (IMI) to Improve Drinking Outcomes Among Women

September 17, 2019 updated by: Public Health Institute, California

A Phase II Randomized Clinical Trial (RCT) is proposed to compare a 9-session model of intensive motivational interviewing (IMI) to standard motivational interviewing techniques (SMI) among alcohol dependent women. Preliminary work studying 87 women randomly assigned to IMI or a standard single session of motivational interviewing showed significantly better drinking outcomes for women in the IMI condition at 4- and 6-month follow-up. Interestingly, mean trajectories for women assigned to IMI showed continuing declines in drinking problems during and after treatment. Differences between study conditions grew larger between 4-month (p<.05) and 6-month (p<.01) follow-up and the effect size at 6 months was medium to large (Cohen's d=0.63) The study will use mixed model quantitative and qualitative methods to respond to the PA's call for studies assessing mechanisms of change. Unlike many previous studies of SMI, we will employ limited exclusion criteria and will enroll participants who present with co-existing drug and psychiatric disorders.

Procedures for the proposed study draw from our current successful RCT assessing IMI for methamphetamine (MA) dependence. Successful aspects of the current study include achievement of recruitment goals, strong adherence to the treatment and research protocols, and excellent rates for follow-up interviews (>90%). The proposed study will take place at the same outpatient treatment program as the current study, New Leaf Treatment Center in Lafayette, California.

Participants will include 220 alcohol dependent women who will be randomly assigned to IMI or SMI. Those in SMI will also receive an attention component (nutrition education) to achieve time equivalence between the two study conditions. Participants in both groups will receive standard weekly group treatment offered at the program. In addition, referrals to Alcoholics Anonymous will be provided to all participants. The primary outcomes will be measures of drinking, heavy drinking (4+ drinks), and severity of alcohol problems assessed at baseline and 2, 6, and 12 months. Secondary outcomes will include Addiction Severity Index scales, psychiatric problems, and symptoms of trauma. The study will include standard quantitative testing of potential mediators, including, the therapeutic alliance, self-efficacy, motivation, satisfaction, and use of outside services. However, the application also proposes an innovative use of qualitative procedures to identify unrecognized factors influencing outcome.

Study Overview

Detailed Description

The proposed study responds to the Program Announcement PA-10-100, "Alcohol Use Disorders: Treatment, Services Research, and Recovery" (R01) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Our application addresses the priorities of this announcement by proposing a phase II randomized clinical trial comparing intensive motivational interviewing (IMI) to standard motivational interviewing techniques (SMI) for alcohol dependent women. The study will use mixed model quantitative and qualitative methods to respond to the program announcement's call for studies assessing mechanisms of change. Unlike many previous studies of SMI we will employ limited exclusion criteria and will enroll participants who present with co-existing drug and psychiatric disorders.

SMI was initially developed as a brief intervention (typically 1-3 sessions) for the treatment of problem drinkers (Miller & Rollnick, 2002). The general strategy of SMI is to strategically combine supportive and directive interventions as a way to elicit ambivalence about substance use (i.e., pros and cons) and thereby increase motivation for change. Systematic reviews of the alcohol treatment literature have consistently shown SMI to be effective for treating alcohol use disorders (Hettema, Steele, & Miller, 2005; Dunn, Deroo, Rivera, 2001). Studies have shown SMI to be effective as a stand-alone treatment for alcohol problems (Project MATCH Research Group, 1997; Miller, 1993; Sellman, Sullivan, Dore, Adamson, & MacEwan, 2001) and as preparation for more intensive treatment (Burke, Arkowitz, & Menchola, 2003). Perhaps the best-known and largest study of an SMI based was an assessment of "motivational enhancement therapy" (MET) as a stand-alone, 4 session condition conducted by the Project MATCH Research Group (Sellman, Sullivan, Dore, Adamson, & MacEwan, 2001; Project MATCH Research Group, 1998). Participants were randomly assigned to 4 sessions of MET, 12 sessions of cognitive behavioral counseling (CBT), or 12 sessions of 12-step facilitation (TSF). Despite fewer sessions in MET, outcomes among the 3 conditions were comparable. A limitation of the study was that individuals with serious co-occurring drug or mental health problems were excluded as were those with housing instability.

Like Project MATCH, most studies of SMI for alcohol problems have excluded participants who have serious co-occurring drug and mental health problems. However, these are precisely the types of individuals that treatment practitioners are likely to encounter in publicly funded treatment programs. When SMI interventions have targeted illicit drug dependence the results have been mixed. While a number of reviews (Dunn, Deroo, Rivera, 2001) and meta-analyses (Burke, Arkowitz, & Menchola, 2003; Hettema, Steele, & Miller, 2005) have concluded standard low-dose SMI is effective as preparation for more intensive drug treatment, some studies contradict these findings (Downey, Rosengren, & Donovan, 2001; Miller, Yahne, Tonigan, 2003; Winhusen et al., 2008; Mullins, Suerez, Ondersman, Page, 2004; Schneider, Casey, Kohn, 2000). When effects have been found for drug and co-occurring disorders they have most commonly been for retention, not substance use (Carroll et al., 2006).

Procedures for the proposed study draw from our current successful RCT assessing IMI for MA dependence. Successful aspects of the current study include achievement of recruitment goals, strong adherence to the treatment and research protocols, and excellent rates for follow-up interviews (>90%). The proposed study will take place at the same outpatient treatment program as the current study, New Leaf Treatment Center in Lafayette, California. Two hundred and twenty alcohol dependent women will be randomly assigned to IMI or SMI with an attention component for time equivalence (nutrition education). Participants in both groups will receive standard group treatment offered at the program. The primary outcomes will be measures of drinking, heavy drinking (4+ drinks), and severity of alcohol problems assessed at baseline and 2, 6, and 12 months. Secondary outcomes will include Addiction Severity Index scales, psychiatric problems, and symptoms of trauma. The study will include standard quantitative testing of potential mediators, including, the therapeutic alliance, self-efficacy, motivation, satisfaction, and use of outside services. However, the application also proposes an innovative use of qualitative procedures to identify unrecognized factors influencing outcome.

Aim 1: To compare drinking and alcohol problems among women receiving IMI and SMI.

Hypothesis 1.1: During the active phase of treatment (weeks 1-9) women in IMI will have fewer positive breathalyzer screens, drinking days, and heavy drinking days (4+ drinks) than women in SMI.

Hypothesis 1.2: Women in IMI will demonstrate fewer drinking days and heavy drinking days (4+ drinks) and lower scores on the Addiction Severity Index (ASI) Alcohol Scale at 2, 6, and 12 months.

Aim 2: To assess potential mediators of drinking and alcohol problems. Hypothesis 2.1: Measures of retention, therapeutic alliance, social support, and motivation will mediate the relationship between study condition and drinking outcome.

Aim 3: To Use qualitative interviews to identify additional factors that influence outcome. Content areas will include perceptions of the therapist, IMI & SMI interventions, the CBT group, and external influences such as Alcoholics Anonymous (AA), intimate partners, friends, and family.

Exploratory Aims: 1) To compare IMI and SMI outcomes on ASI scales, psychiatric symptoms, AA involvement, and trauma symptoms.

Study Type

Interventional

Enrollment (Actual)

215

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Lafayette, California, United States, 94549
        • New Leaf Treatment Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

1) Female 2)18 years or older 3) meets DSM-V criteria for current alcohol use disorder in the past 30 days, as assessed by the DSM-V Checklist, defined as 2 or more criterion 4) alcohol in the past 30 days and medically cleared by NLTC medical personnel 5) able to speak and read English, 6) capable of giving informed consent 7) likely to be in the area the next 12 months.

Exclusion Criteria:

  1. has had alcohol in the past 3 days and may require medical treatment for alcohol or drug detoxification and is not followed by a physician or has not been medically cleared by NLTC medical personnel
  2. or has unmet needs for treatment of serious medical or psychiatric conditions
  3. any condition that would impair their ability to provide informed consent
  4. current severe drug use disorder, defined as 6 or more DSM-V criteria in the past 30 days, 5.)Currently enrolled in alcohol or drug treatment

6) Does not meet DSM-V criteria for current alcohol use disorder as assessed by the DSM-V Checklist, 7) Refuses to sign HIPPA authorization form 8) Any medical or psychosocial condition that would preclude safe, useful, or consistent participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 9 sessions of Intensive Motivational Interviewing
Experimental condition will consist of 9 1-hour intensive motivational interviewing sessions.
Weekly individual therapy sessions over 9 weeks (Intensive MI condition) consisting of supportive and directive interventions. The control condition consists on a single session of MI and nutritional education.
Active Comparator: 1 Standard Motivational Interview plus 8 nutrition classes
The standard MI intervention will consist of a commonly used, single session of MI (50 minutes) plus 8 hours of nutrition education to achieve time and attention equivalence of study conditions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the number of drinks and frequency of drinks in the past two months
Time Frame: Baseline, 2 months, 6 months, and 12 months
Change in daily drinking patterns (quantity and frequency) over the past two months using the Timeline follow-back assessment
Baseline, 2 months, 6 months, and 12 months
Change in the severity of alcohol use within past 30 days
Time Frame: Baseline, 2 months, 6 months, and 12 months
Change in alcohol Addiction Severity Index (ASI) scores in the past 30 days
Baseline, 2 months, 6 months, and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in employment, psychiatric status, and legal status over the past 30 days
Time Frame: Baseline, 2 months, 6 months, and 12 months
Change in employment, psychiatric status, and legal status over the past 30 days as assessed by the Addiction Severity Index (ASI)
Baseline, 2 months, 6 months, and 12 months
Change in mental health
Time Frame: Baseline, 2 months, 6 months, and 12 months
Change in emotions, moods, thoughts, and behaviors in the past two weeks as assessed by the Psychiatric Diagnostic Screening Questionnaire (PDSQ)
Baseline, 2 months, 6 months, and 12 months
Change in trauma and stress levels
Time Frame: Baseline, 2 months, 6 months, and 12 months
Change in drinking consequences scores as assessed by Alcohol and Drug Consequences Questionnaire (ADCQ)
Baseline, 2 months, 6 months, and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Douglas Polcin, Ed.D., Alcohol Research Group / Public Health Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2015

Primary Completion (Actual)

March 1, 2019

Study Completion (Actual)

March 7, 2019

Study Registration Dates

First Submitted

October 20, 2014

First Submitted That Met QC Criteria

October 20, 2014

First Posted (Estimate)

October 22, 2014

Study Record Updates

Last Update Posted (Actual)

September 18, 2019

Last Update Submitted That Met QC Criteria

September 17, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • R01AA022857 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Use Disorders

Clinical Trials on Intensive Motivational Interviewing

3
Subscribe